Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe
Gutierrez-Aguirre, C.H, Cantu-Rodriguez, O.G, Gonzalez-Llano, O, Jaime-Perez, J.C, Mancias-Guerra, C, Flores-Jimenez, J.A, Alatorre-Ricardo, J, Gomez-Almaguer, D
Published in Biology of blood and marrow transplantation (2012)
Published in Biology of blood and marrow transplantation (2012)
Get full text
Journal Article